<p>sFRP3, 2<sup>nd</sup> tertile <i>vs</i>. 1<sup>st</sup> and 3<sup>rd</sup> tertile, as predictor of outcome. All Hazard Ratios (HR) are given as HR (95% confidence interval). C index, Δ; difference in C index between fully adjusted model with and without inclusion of sFRP3, corresponding (<i>p</i>-value). Net Reclassification Improvement (NRI); calculated from C-indexes for fully adjusted models with and without inclusion of sFRP3, corresponding (<i>p</i>-value). Unadjusted (n = 1444). The models are adjusted as follows: Step 1 (n = 1441): Ejection fraction, New York Heart Association functional class, age, body mass index, diabetes mellitus, sex, intermittent claudication and heart rate. Step 2 (n = 1428): All variables from Step 1 as w...
<p><b>Model 1:</b> adjusted for age and sex.</p><p><b>Model 2:</b> adjusted for model 1, heart rate,...
<p>Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; OR, odds rati...
<p><b>A.</b> ischemic HF <70 years of age <b>B.</b> ischemic HF >70 years of age <b>C.</b> non-ische...
<p>NT-proBNP and CRP are displayed as median value (interquartile range). Other variables are shown ...
<p>BMI, body mass index; NYHA, New York Heart Association; eGFR, estimated glomerular filtration rat...
<p>HR: Hazard ratio, CI: confidence interval. In bold, variables with p-value < 0.05, included in th...
<p><b>Association of ST2 with CRP levels dichotomized as high or low according to the median of each...
We have previously demonstrated an association between increased sFRP3 expression and adverse outcom...
Background We have previously demonstrated an association between increased sFRP3 expression and adv...
Galectin-3 and ST2 are emerging biomarkers involved in myocardial fibrosis. We evaluate the relevanc...
We have previously demonstrated an association between increased sFRP3 expression and adverse outcom...
Background: The Seattle heart failure model or the cardiac and comorbid conditions (3C-HF) scores ma...
<p><sup>1</sup> Adjusted by age, sex, diabetes</p><p><sup>2</sup> Adjusted by sex, diabetes</p><p><s...
ObjectivesST2 and galectin-3 (Gal-3) were compared head-to-head for long-term risk stratification in...
<p>Lowest tertile: ANGPTL2 level ≤3.4 ng/mL; middle tertile: 3.4 ng/mL< ANGPTL2 level ≤ 4.8 ng/mL; h...
<p><b>Model 1:</b> adjusted for age and sex.</p><p><b>Model 2:</b> adjusted for model 1, heart rate,...
<p>Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; OR, odds rati...
<p><b>A.</b> ischemic HF <70 years of age <b>B.</b> ischemic HF >70 years of age <b>C.</b> non-ische...
<p>NT-proBNP and CRP are displayed as median value (interquartile range). Other variables are shown ...
<p>BMI, body mass index; NYHA, New York Heart Association; eGFR, estimated glomerular filtration rat...
<p>HR: Hazard ratio, CI: confidence interval. In bold, variables with p-value < 0.05, included in th...
<p><b>Association of ST2 with CRP levels dichotomized as high or low according to the median of each...
We have previously demonstrated an association between increased sFRP3 expression and adverse outcom...
Background We have previously demonstrated an association between increased sFRP3 expression and adv...
Galectin-3 and ST2 are emerging biomarkers involved in myocardial fibrosis. We evaluate the relevanc...
We have previously demonstrated an association between increased sFRP3 expression and adverse outcom...
Background: The Seattle heart failure model or the cardiac and comorbid conditions (3C-HF) scores ma...
<p><sup>1</sup> Adjusted by age, sex, diabetes</p><p><sup>2</sup> Adjusted by sex, diabetes</p><p><s...
ObjectivesST2 and galectin-3 (Gal-3) were compared head-to-head for long-term risk stratification in...
<p>Lowest tertile: ANGPTL2 level ≤3.4 ng/mL; middle tertile: 3.4 ng/mL< ANGPTL2 level ≤ 4.8 ng/mL; h...
<p><b>Model 1:</b> adjusted for age and sex.</p><p><b>Model 2:</b> adjusted for model 1, heart rate,...
<p>Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; OR, odds rati...
<p><b>A.</b> ischemic HF <70 years of age <b>B.</b> ischemic HF >70 years of age <b>C.</b> non-ische...